Optimal Sampling Times in Population Pharmacokinetic Studies
Optimal Sampling Times in Population Pharmacokinetic Studies
SUMMARY We propose a simulation-based approach to decision theoretic Bayesian optimal design. The underlying probability model is a population pharmacokinetic model which allows for correlated responses (drug concentrations) and patient-to-patient heterogeneity. We consider the problem of choosing sampling times for the anticancer agent paclitaxel, using criteria related to the total …